Prosecution Insights
Last updated: August 17, 2026

Examiner: MOLOYE, TITILAYO

Tech Center 1600 • Art Units: 1600 1615 1631 1632

This examiner grants 63% of resolved cases

Performance Statistics

63.1%
Allow Rate
+3.1% vs TC avg
587
Total Applications
+47.1%
Interview Lift
1336
Avg Prosecution Days
Based on 545 resolved cases, 2023–2026

Rejection Statute Breakdown

4.5%
§101 Eligibility
11.1%
§102 Novelty
40.0%
§103 Obviousness
32.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18305863 Methods and Compositions for Modifying a Mutant Dystrophin Gene in a Cell's Genome Non-Final OA The Regents of the University of California
17999756 COMPOSITIONS AND METHODS FOR GENE EDITING Non-Final OA The Regents of the University of California
18432439 Biosensors in Human Gut Organoids Non-Final OA Massachusetts Institute of Technology
18361584 METHODS AND SYSTEMS FOR FUNCTIONAL MATURATION OF iPSC AND ESC DERIVED CARDIOMYOCYTES Non-Final OA Agilent Technologies, Inc.
17626042 THERAPEUTIC AGENT FOR DISEASE CAUSED BY DOMINANT MUTANT GENE Non-Final OA RIKEN

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month